Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy.
Te-Fu LinPing-I HsuKung-Hung LinFeng-Woei TsayTzung-Jiun TsaiYan-Hua ChenHsien-Chung YuPublished in: Gastroenterology research and practice (2017)
Telbivudine is an alternative drug of choice for the treatment of hepatitis B patients for whom renal safety is a concern, especially patients with DM and CKD-3.